- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03810885
SalT Reduction InterVEntion: Metabolic, Behavioral and Health Consequences of Reducing Salt in Bread (STRIVE)
SalT Reduction InterVEntion: Examination of the Metabolic, Behavioral and Health Consequences of Reducing Salt Intake. A Randomized Controlled Trial in a Real Life Setting
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The trial is conducted as a randomized controlled trial including children and adults recruited as families. The families are randomly allocated into three groups to investigate the effect of different salt reduction strategies in a period of 3-4 months. Families in the first intervention group are receiving salt reduced bread. Families in the second intervention group are receiving salt reduced bread in combination with dietary counselling to reduce salt and increase potassium intake. Families in the control group are receiving bread with a regular content of salt and no dietary counselling.
Participants will be instructed to replace their usual consumption of bread by the bread products provided in the study. In all other respects, participants will be requested to live their lives as usual without changing any habits, except the families receiving dietary counselling. The participants will be unaware of the treatment groups and the salt content of the bread products will be blinded to the participants.
Families will attend a physical examination at baseline and at 3-4 months follow-up. The health examination includes anthropometrics, blood pressure measurements and blood samplings for analysis of glucose, lipid metabolism and hormone balance. Urine samples will be collected to investigate the sodium and potassium content. Furthermore salt-sensitivity and preference tests will be made. After both health examinations the families will collect three repeated 24-hour urine collections at home and fill in a 7 days dietary record.
After data collection, blood and urine samples will be analysed. Analyses from both baseline and follow-up are expected ultimo February 2019, whereby data cleaning and statistical analyses will be performed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Capital Region
-
Glostrup, Capital Region, Denmark, 2600
- Center fot Clinical Research and Prevention
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants living with children
- Adults 18-69 years
- Children 3-17 years
- Daily intake of bread
Exclusion Criteria:
- Diabetes
- Cardiovascular disease
- Antihypertensive treatment
- Lipid-lowering treatment
- Pregnancy
- U-albumin > 300 mg/day
- Celiac disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Salt reduced bread
Bread with reduced salt content
|
Bread with gradually lowered salt content
|
Experimental: Dietary advice and Salt reduced bread
bread with reduced salt content, dietary advice
|
Bread with gradually lowered salt content
Participants will receive information on how to lower salt and increase potassium intake
|
Placebo Comparator: Normal bread
Bread with standard salt content
|
Bread with normal salt content
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline sodium level in 24 hour urine at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Adults average of 3 repeated 24 hour urine, children a single 24hour urine collection; excluding urine first morning including urine of the following morning.
Completeness evaluated in adults by Para-Amino-Benzoic-Acid (PABA).
|
Measurements at Baseline and at 4 month.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline potassium level in 24 hour urine at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Adults average of 3 repeated 24 hour urine, children a single 24hour urine collection; excluding urine first morning including urine of the following morning.
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Systolic blood pressure at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Systolic blood pressure measured at baseline and follow-up .
Average of three measurements, with the participant sitting upright at rest.. Minimum 2 hours fasting.
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Diastolic blood pressure at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Diastolic blood pressure measured at baseline and follow-up .
Average of three measurements, with the participant sitting upright at rest.. Minimum 2 hours fasting.
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Adrenaline and Noradrenaline levels in plasma at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
blood sampled, stored on ice, with the participant lying down after 30 minutes of rest.
Minimum 2 hours of fasting.
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Renin and Aldosterone levels in plasma at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
blood sampled, with the participant lying down after 30 minutes of rest.
Minimum 2 hours of fasting.
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Salt sensitivity and preference at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Sensory test: Sensitivity and preference test, minimum 2 hours of fasting
|
Measurements at Baseline and at 4 month.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Glucose levels in plasma at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
blood sampled, with the participant lying down after 30 minutes of rest.
Minimum 2 hours of fasting.
|
Measurements at Baseline and at 4 month.
|
Change from Baseline HbA1C levels in full blood at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
blood sampled, with the participant lying down after 30 minutes of rest.
Minimum 2 hours of fasting.
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Cholesterol levels in plasma (LDL, HDL, total cholesterol and triglycerides) at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
blood sampled, with the participant lying down after 30 minutes of rest.
Minimum 2 hours of fasting.
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Height in centimetres at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Measured in centimetres to the closest decimal, without shoes or socks, with clothes on
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Weight in kilograms at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Measured in kilograms to the closest decimal, without shoes or socks, with clothes on
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Impedance in ohm at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Measured in ohm to the closest decimal, without shoes or socks, with clothes on
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Hip circumference in centimetres at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Measured on bare skin to nearest decimal
|
Measurements at Baseline and at 4 month.
|
Change from Baseline Waist circumference in centimetres at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Measured on bare skin to nearest decimal
|
Measurements at Baseline and at 4 month.
|
Baseline Albumin in spot urine
Time Frame: Measurements at Baseline
|
Not morning urine, minimum 2 hours of fasting
|
Measurements at Baseline
|
Change from Baseline Sodium, potassium and creatinine level in spot urine at 4 months
Time Frame: Measurements at Baseline and at 4 month.
|
Not morning urine, minimum 2 hours of fasting
|
Measurements at Baseline and at 4 month.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ulla Toft, MSc, PhD, Capital Region, Copenhagen, Denmark
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H-17030995
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Salt Intake
-
St Mary's University CollegeUnknown
-
Brigham and Women's HospitalTerminatedAutoimmunity | Sodium Chloride | Salt Intake | Th17 Helper Immune CellsUnited States
-
Josip Juraj Strossmayer University of OsijekUnknown
-
University of California, DavisUniversity of California, San Francisco; Ethiopian Public Health Institute; Nutrition...Enrolling by invitationFolate Deficiency | Iodine Deficiency | Anemia, Macrocytic | Anemia Deficiency | Salt IntakeEthiopia
-
Josip Juraj Strossmayer University of OsijekRecruitingPregnancy Related | Salt; ExcessCroatia
-
The George InstituteCompletedReducing Salt in the Food Supply
-
Rio de Janeiro State UniversityUniversidade Federal do Rio de JaneiroCompletedPhysical Activity | Sugar Intake | Beverage Intake | Fruit Intake | Beans IntakeBrazil
-
University of California, DavisUniversity of California, San Francisco; University of Rhode Island; Ethiopian... and other collaboratorsEnrolling by invitationVitamin B 12 Deficiency | Folate Deficiency | Iodine Deficiency | Anemia Deficiency | Salt Intake | Anemia MacrocyticEthiopia
-
University of Maryland, BaltimoreCompletedBile Salt Export Pump (BSEP) Transporter | Polysorbate 80United States
Clinical Trials on Bread with reduced salt content
-
University of AberdeenUnknownNon Coeliac Gluten SensitivityUnited Kingdom
-
West German Center of Diabetes and HealthBakery HinkelCompleted
-
Liita Care ApSUnknownObstructive Airway DiseasesDenmark
-
Liita Care ApSSuspendedCOPD | Copd BronchitisDenmark
-
University of BariCompletedIrritable Bowel Syndrome | Gluten Sensitivity
-
University College CorkCompletedElevated Blood PressureIreland
-
The George InstituteUniversity of Abuja Teaching HospitalActive, not recruitingBlood PressureNigeria
-
KU LeuvenRecruitingAppetite Regulation | Energy IntakeBelgium
-
Umeå UniversityCompleted
-
Milton S. Hershey Medical CenterNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)CompletedOxidative Stress | NicotineUnited States